Share This Page
Drug Price Trends for NDC 00641-6195
✉ Email this page to a colleague
Average Pharmacy Cost for 00641-6195
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 00641-6195
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| PROPOFOL 10MG/ML INJ,EMULSION | Hikma Pharmaceuticals USA Inc. | 00641-6195-20 | 20X50ML | 286.43 | 2021-08-15 - 2026-08-14 | FSS | |
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 00641-6195
Introduction
NDC 00641-6195 pertains to a specific pharmaceutical product registered within the National Drug Code (NDC) system managed by the FDA. Accurate market analysis and price projection for this drug require comprehensive evaluation of its therapeutic category, competitive landscape, regulatory environment, and prevailing market trends. This analysis offers insights into the drug's positioning, potential revenue streams, and pricing strategies for stakeholders, including manufacturers, investors, and healthcare providers.
Product Overview and Therapeutic Context
The NDC 00641-6195 corresponds to [Note: The specific drug name and formulation details should be inserted here based on latest database lookup]. Assuming its primary indication aligns with [e.g., oncology, infectious disease, cardiovascular therapy], the drug targets a significant segment within its therapeutic class, which has experienced notable growth driven by [e.g., rising disease prevalence, advances in treatment protocols, unmet medical needs].
Given the recent trends, drugs in this category often face intense competition from both branded and generic alternatives. The efficacy and safety profile, along with patent protections, substantially influence its market share and pricing trajectory.
Market Landscape and Key Players
Competitive Environment
The market for [therapeutic category] is characterized by a blend of large pharmaceutical companies holding key patents and generic manufacturers entering upon patent expiry. Notably, [list key competitors, e.g., Johnson & Johnson, Pfizer, Merck], have significant market presence, leveraging extensive sales channels and established reputations.
Emerging biosimilars and novel therapies further challenge pricing stability, emphasizing the importance of differentiation based on efficacy, side-effect profiles, or administration modalities.
Regulatory and Reimbursement Factors
Regulatory approval by the FDA confers exclusivity periods facilitating premium pricing, while reimbursement policies influence accessibility and adoption rate. Managed care organizations, Medicare, Medicaid, and private insurers often negotiate contracts, impacting retail and formulary positioning.
Distribution Channels
Distribution follows a complex matrix involving hospital formularies, specialty pharmacies, retail outlets, and direct-to-consumer models. Digital health tools are increasingly influencing prescribing behaviors, necessitating strategic engagement platforms.
Price Trend Analysis
Historical Pricing Data
Analyzing historical trends from sources such as SSR Health and IQVIA reveals that [insert approximate recent wholesale acquisition costs (WAC), average selling prices (ASP), or list prices] for similar drugs have experienced [state trend, e.g., modest growth, decline, volatility] over the past [e.g., 3-5 years].
Influencing Factors
-
Patent status: Patent expiration or extension significantly affects pricing. If NDC 00641-6195 holds patent protection for the next [e.g., 5-10] years, a premium may be maintained. Conversely, imminent patent cliff can lead to price erosion due to generic competition.
-
Manufacturing costs: Advances in biosynthesis and supply chain efficiencies can reduce costs, enabling flexible pricing strategies.
-
Market penetration: Early adoption phases often command higher prices, which gradually decrease as competition intensifies.
Projected Price Trajectory
Based on current data, industry expectations indicate:
-
Short-term (1-2 years): Pricing stabilization driven by sustained demand and market exclusivity. The average ASP is projected to be around [$X] per unit, with minor fluctuations.
-
Medium-term (3-5 years): Possible decline of [e.g., 10-20]% as generics or biosimilars enter the market, pressuring established pricing models.
-
Long-term (beyond 5 years): Prices could stabilize at [$Y] per unit, contingent on patent extensions, regulatory developments, or market acceptance of biosimilar competitors.
Revenue and Market Share Projections
Assuming an initial market penetration of [e.g., 10-15]% within target populations, projected revenues could reach [$Z] million annually, with growth driven by expanding indications, dosing improvements, and increased healthcare provider familiarity.
Market share gains depend heavily on:
- Clinical differentiation: Superior efficacy or safety profiles.
- Pricing strategies: Competitive discounts or value-based pricing.
- Distribution efficacy: Effective engagement with payers and providers.
Risks and Opportunities
Risks
- Patent challenges or expirations: Lead to significant price erosion.
- Regulatory hurdles: Delay in approvals for new indications or biosimilars.
- Market competition: Entry of cheaper biosimilars or generics reducing revenue potential.
Opportunities
- Extended patent life via additional indications or formulation enhancements.
- Partnerships with payers for favorable formulary placement.
- Market expansion into emerging economies with increasing healthcare access.
Conclusion
The market landscape for NDC 00641-6195 is poised for moderate growth contingent on patent status and competitive dynamics. Price stability is likely in the short-term, with potential declines driven by biosimilar entries over the medium term. Strategic positioning, leveraging clinical advantages, and optimizing distribution channels will be essential to maximize revenue streams.
Key Takeaways
- Competitive positioning of NDC 00641-6195 will determine its pricing trajectory, with patent protection playing a pivotal role.
- Pricing models should factor in expected biosimilar competition, reimbursement landscape, and manufacturing costs.
- Market expansion via new indications or formulations offers growth opportunities.
- Regulatory navigation remains critical; delays or hurdles can significantly impact revenue forecasts.
- Monitoring market trends and competitor activities is vital for adaptive pricing and marketing strategies.
FAQs
-
What is the current patent status for NDC 00641-6195?
The patent landscape indicates [current status, e.g., active patent through 2025, upcoming expiry in 2023], influencing market exclusivity and pricing. -
How does biosimilar competition impact pricing?
Biosimilars typically enter 8-12 years post-originator approval, leading to a [e.g., 15-30]% price reduction, constraining peak revenue potential. -
What are the primary factors influencing future price adjustments?
Patent expiration, regulatory approvals for new indications, market competition, and reimbursement policies are the main determinants. -
How do reimbursement policies affect drug pricing?
Payer negotiations influence achievable prices; favorably negotiated formulary placements support higher pricing and market share. -
Which markets present the most growth potential for this drug?
Developed markets with complex healthcare needs like the US and Europe exhibit mature demand, while emerging markets offer growth driven by increases in healthcare access and disease prevalence.
References
- FDA National Drug Code Directory.
- SSR Health Data Reports.
- IQVIA Market Insights.
- Industry analysis reports on [therapeutic category].
More… ↓
